Genome wiz Venter partners with Roche in DNA sequencing deal
Jan 15, 2015, 00:00 AM
by
Michael Croft
Reuters | Genome pioneer J. Craig Venter has
signed a multi-year deal to sequence and analyze tens of thousands
of genomes for Roche's Genentech unit in a deal aimed at
identifying new drug targets.
January 15, 2015 | Genome pioneer J. Craig Venter has signed a multi-year deal to sequence and analyze tens of thousands of genomes for Roche's Genentech unit in a deal aimed at identifying new drug targets. Reuters